We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
TechnipFMC
FTI
$30.6B
| $12.6M | 0.12% |
618,096
+525,924
| +571% | +$9.93M |
|
|
TVPT
177
DELISTED
Travelport Worldwide Limited
TVPT
| $12.5M | 0.12% |
916,896
-84,721
| -8% | -$1.02M |
|
178
Atmos Energy
ATO
$29.9B
| $12.3M | 0.12% |
165,237
-190,993
| -54% | -$13.1M |
|
179
Antero Resources
AR
$10.9B
| $12.3M | 0.12% |
492,951
+43,323
| +10% | +$1.04M |
|
180
Diamondback Energy
FANG
$57.6B
| $12.2M | 0.12% |
158,493
+147,951
| +1,403% | +$10.4M |
|
181
Applied Materials
AMAT
$426B
| $12.2M | 0.12% |
574,867
-275,327
| -32% | -$5.02M |
|
182
Curtiss-Wright
CW
$27.7B
| $12.1M | 0.12% |
159,282
-52,529
| -25% | -$3.64M |
|
183
Weyerhaeuser
WY
$17.3B
| $12M | 0.12% |
388,058
-35,480
| -8% | -$947K |
|
|
FDC
184
DELISTED
First Data Corporation
FDC
| $12M | 0.12% |
927,343
-82,586
| -8% | -$1.06M |
|
|
CBPX
185
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $12M | 0.12% |
+645,873
| New | +$10.5M |
|
186
Enovis
ENOV
$1.56B
| $12M | 0.12% |
242,911
+28,650
| +13% | +$1.22M |
|
|
ADT
187
DELISTED
ADT Corp
ADT
| $11.9M | 0.11% |
288,981
+276,490
| +2,214% | +$9.7M |
|
188
ICU Medical
ICUI
$3.93B
| $11.8M | 0.11% |
113,437
-1,117
| -1% | -$107K |
|
189
Core Laboratories
CLB
$538M
| $11.6M | 0.11% |
+103,592
| New | +$10.8M |
|
|
HPY
190
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $11.6M | 0.11% |
+120,537
| New | +$11.1M |
|
|
APC
191
DELISTED
Anadarko Petroleum
APC
| $11.5M | 0.11% |
247,541
+201,678
| +440% | +$8.18M |
|
|
PPLI
192
People Inc
PPLI
$3.1B
| $11.5M | 0.11% |
1,367,456
-3,411,095
| -71% | -$29.4M |
|
193
Mohawk Industries
MHK
$6.9B
| $11.5M | 0.11% |
+60,149
| New | +$10.5M |
|
194
Nasdaq
NDAQ
$51.5B
| $11.4M | 0.11% |
+516,051
| New | +$10.6M |
|
195
RLJ Lodging Trust
RLJ
$1.87B
| $11.4M | 0.11% |
498,236
+267,872
| +116% | +$5.4M |
|
|
ITC
196
DELISTED
ITC HOLDINGS CORP
ITC
| $11.3M | 0.11% |
258,677
-157,013
| -38% | -$6.38M |
|
197
Teva Pharmaceuticals
TEVA
$35.9B
| $11.2M | 0.11% |
210,159
-922,492
| -81% | -$54.1M |
|
198
Nike
NKE
$61.9B
| $11.2M | 0.11% |
182,744
-463,372
| -72% | -$28M |
|
|
SEM
199
DELISTED
Select Medical
SEM
| $11.2M | 0.11% |
1,758,315
+630,660
| +56% | +$3.38M |
|
200
Merck
MRK
$324B
| $11.2M | 0.11% |
221,026
-245,208
| -53% | -$12M |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.